Ex-AstraZeneca Exec Morrison Grabs Helm at Syndax Pharma
Waltham, MA-based Syndax Pharmaceuticals named former AstraZeneca chief medical officer Briggs Morrison its new CEO, and Michael Metzger, onetime Regado Biosciences president and CEO, its new president. Morrison and and Metzger are replacing former leader Arlene Morris—whose name was conspicuously absent from the news release. FierceBiotech first reported news of Morrison’s departure from AstraZeneca last week. Read more here for the immuno-oncology focused strategy that Syndax—which flirted with an IPO last year under Morris—intends to pursue.
Underwriters and Partners
Xconomy Insight · Special Report
Starting a Biotech Company: What Every Entrepreneur Needs to Know
Get advice from the experts to help your biotech startup succeed
From Our Editors · Special Report
2019 Blockchain Outlook — Reality Check
Reality Check
Xconomy
From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Facing an Uncertain Future
Xconomy
Wisconsin helps biotech company raise $20 million
See how TAI Diagnostics achieved accelerated growth
Wisconsin Economic Development Corporation